SI1896034T1 - Mikronizirani sestavki tanaprogeta in postopki priprave le-tega - Google Patents

Mikronizirani sestavki tanaprogeta in postopki priprave le-tega

Info

Publication number
SI1896034T1
SI1896034T1 SI200630649T SI200630649T SI1896034T1 SI 1896034 T1 SI1896034 T1 SI 1896034T1 SI 200630649 T SI200630649 T SI 200630649T SI 200630649 T SI200630649 T SI 200630649T SI 1896034 T1 SI1896034 T1 SI 1896034T1
Authority
SI
Slovenia
Prior art keywords
preparing
methods
same
micronized tanaproget
tanaproget compositions
Prior art date
Application number
SI200630649T
Other languages
English (en)
Inventor
Arwinder Nagi
Ramarao Chatlapalli
Shamim Hasan
Mohamed Ghorab
Dhaval Gaglani
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of SI1896034T1 publication Critical patent/SI1896034T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SI200630649T 2005-04-28 2006-04-26 Mikronizirani sestavki tanaprogeta in postopki priprave le-tega SI1896034T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67555005P 2005-04-28 2005-04-28
EP06751506A EP1896034B8 (en) 2005-04-28 2006-04-26 Micronized tanaproget compositions and methods of preparing the same
PCT/US2006/015837 WO2006116514A2 (en) 2005-04-28 2006-04-26 Micronized tanaproget, compositions, and methods of preparing the same

Publications (1)

Publication Number Publication Date
SI1896034T1 true SI1896034T1 (sl) 2010-07-30

Family

ID=37023145

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630649T SI1896034T1 (sl) 2005-04-28 2006-04-26 Mikronizirani sestavki tanaprogeta in postopki priprave le-tega

Country Status (19)

Country Link
US (4) US7767668B2 (sl)
EP (1) EP1896034B8 (sl)
JP (2) JP5149159B2 (sl)
CN (1) CN101166532B (sl)
AR (1) AR056328A1 (sl)
AT (1) ATE460937T1 (sl)
AU (1) AU2006241113B2 (sl)
BR (1) BRPI0610437A2 (sl)
CA (1) CA2603806C (sl)
CY (1) CY1110009T1 (sl)
DE (1) DE602006012972D1 (sl)
DK (1) DK1896034T3 (sl)
ES (1) ES2340610T3 (sl)
MX (1) MX2007013465A (sl)
PL (1) PL1896034T3 (sl)
PT (1) PT1896034E (sl)
SI (1) SI1896034T1 (sl)
TW (1) TW200716129A (sl)
WO (1) WO2006116514A2 (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1848414T3 (pl) 2005-02-03 2011-10-31 Wyeth Llc Sposób leczenia nowotworu opornego na gefitinib
BRPI0610431A2 (pt) * 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, processo para preparar uma composição, cápsula, e, kit farmacêutico
AU2006241113B2 (en) * 2005-04-28 2011-08-18 Wyeth Micronized tanaproget, compositions, and methods of preparing the same
DE602006007453D1 (de) * 2005-04-28 2009-08-06 Wyeth Corp Zusammensetzungen mit mikronisiertem tanaproget
CN101166736B (zh) * 2005-04-28 2013-02-06 惠氏公司 他那普戈特的多晶型ⅱ
WO2006135638A2 (en) 2005-06-09 2006-12-21 Wyeth Tanaproget compositions containing ethinyl estradiol
PE20070763A1 (es) 2005-11-04 2007-08-08 Wyeth Corp COMBINACIONES ANTINEOPLASICAS DE UN INHIBIDOR DE mTOR, TRASTUZUMAB Y/O HKI-272
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
US9040825B2 (en) * 2007-11-13 2015-05-26 Southwire Company, Llc Conductors and metal-covered cable with coded information and method of applying coded information
JP2011507853A (ja) * 2007-12-20 2011-03-10 テバ ウィメンズ ヘルス インコーポレイテッド 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ
CN102641270A (zh) 2008-06-17 2012-08-22 惠氏有限责任公司 含有hki-272和长春瑞滨的抗肿瘤组合
CN102202667A (zh) 2008-08-04 2011-09-28 惠氏有限责任公司 4-苯胺基-3-氰基喹啉和卡培他滨的抗肿瘤组合
MX356593B (es) 2009-04-06 2018-06-05 Wyeth Llc Régimen de tratamiento que utiliza neratinib para cáncer de mama.
RS59599B2 (sr) 2009-11-09 2023-03-31 Wyeth Llc Formulacije tableta neratinib maleata
WO2011056741A2 (en) 2009-11-09 2011-05-12 Wyeth Llc Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
WO2011074961A1 (en) 2009-12-18 2011-06-23 Frieslandcampina Nederland Holding B.V. Co-processed tablet excipient composition its preparation and use
US9326997B2 (en) 2012-09-24 2016-05-03 Ahlam E. Elakkad Composition and method for treation Oligoovulation, Oligomenorrhea and Amenorrhea
AU2014268779A1 (en) 2013-05-21 2016-01-21 Predictive Therapeutics, LLC Therapeutic and method of use
GB201318394D0 (en) * 2013-10-17 2013-12-04 Univ Edinburgh Composition
WO2023025672A1 (en) 2021-08-25 2023-03-02 Basf Se Direct tableting auxiliary composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010214A (pt) * 1999-05-04 2002-02-13 American Home Prod Derivados de ciclotiocarbamato como moduladores de receptores de progesterona
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
CN1665510A (zh) * 2002-06-25 2005-09-07 惠氏公司 作为pr调节剂的环硫代氨基甲酸酯衍生物的衍生物和其用于治疗皮肤病的用途
CN1662241A (zh) 2002-06-25 2005-08-31 惠氏公司 环硫代氨基甲酸酯衍生物在治疗与激素有关的病症中的用途
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
PA8631101A1 (es) 2004-04-27 2006-09-08 Wyeth Corp Proceso de acoplamiento para la generacion de derivados reactivos de pirrol-2-carbonitrilo n-sustituidos con contenido de boro para producir biarilos
MXPA06012403A (es) * 2004-04-27 2007-01-17 Wyeth Corp Purificacion de moduladores de receptor progesterona.
MXPA06012402A (es) * 2004-04-27 2007-01-17 Wyeth Corp Carbamato y tiocarbamato biarilos ciclicos que contienen cianopirrol y metodos para preparar los mismos.
TW200603813A (en) 2004-07-07 2006-02-01 Wyeth Corp Cyclic progestin regimens and kits
GT200500183A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
CN101001863B (zh) * 2004-08-13 2012-10-10 惠氏公司 坦普盖特衍生物、代谢物及其用途
JP2008510722A (ja) * 2004-08-20 2008-04-10 ワイス プロゲステロン受容体構造
CN101166736B (zh) 2005-04-28 2013-02-06 惠氏公司 他那普戈特的多晶型ⅱ
US7786297B2 (en) * 2005-04-28 2010-08-31 Wyeth Llc Purified form of tanaproget
BRPI0610431A2 (pt) * 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, processo para preparar uma composição, cápsula, e, kit farmacêutico
AU2006241113B2 (en) * 2005-04-28 2011-08-18 Wyeth Micronized tanaproget, compositions, and methods of preparing the same
DE602006007453D1 (de) * 2005-04-28 2009-08-06 Wyeth Corp Zusammensetzungen mit mikronisiertem tanaproget
WO2006135638A2 (en) * 2005-06-09 2006-12-21 Wyeth Tanaproget compositions containing ethinyl estradiol

Also Published As

Publication number Publication date
WO2006116514A3 (en) 2006-12-14
CY1110009T1 (el) 2015-01-14
AU2006241113B2 (en) 2011-08-18
US8450312B2 (en) 2013-05-28
JP2008539256A (ja) 2008-11-13
EP1896034B8 (en) 2010-05-19
US20140328925A1 (en) 2014-11-06
PL1896034T3 (pl) 2010-07-30
EP1896034A2 (en) 2008-03-12
AR056328A1 (es) 2007-10-03
CN101166532B (zh) 2011-06-22
BRPI0610437A2 (pt) 2012-10-23
US20060246135A1 (en) 2006-11-02
PT1896034E (pt) 2010-05-06
EP1896034B1 (en) 2010-03-17
WO2006116514A2 (en) 2006-11-02
MX2007013465A (es) 2008-01-21
JP5149159B2 (ja) 2013-02-20
CA2603806A1 (en) 2006-11-02
US20130251807A1 (en) 2013-09-26
DE602006012972D1 (de) 2010-04-29
CN101166532A (zh) 2008-04-23
AU2006241113A1 (en) 2006-11-02
DK1896034T3 (da) 2010-05-17
US20100189789A1 (en) 2010-07-29
US8772271B2 (en) 2014-07-08
TW200716129A (en) 2007-05-01
US7767668B2 (en) 2010-08-03
JP2013006840A (ja) 2013-01-10
CA2603806C (en) 2013-03-19
ES2340610T3 (es) 2010-06-07
ATE460937T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
SI1896034T1 (sl) Mikronizirani sestavki tanaprogeta in postopki priprave le-tega
EP1879659A4 (en) REIZARING COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
IL181543A0 (en) Dendrimer based compositions and methods of using the same
ZA200802490B (en) Isoindole-imide compounds and compositions comprising and methods of using the same
EP1895838A4 (en) COMPOSITIONS AND METHODS
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
EP1881839A4 (en) COMPOSITIONS FROM BACUCHIOL AND METHOD FOR THE PRODUCTION THEREOF
IL184111A0 (en) Prostaglandin-containing compositions and methods for enhancing the stability thereof
ZA200710148B (en) Methods of synthesizing substituted 3-cyanoquinolines and inermediates thereof
IL186400A0 (en) Compositions and methods for the inhibition of dishevelled proteins
ZA200808431B (en) Fungicidal compositions and methods of using the same
PL1951838T3 (pl) Kompozycje zawierające fluoroolefiny i ich zastosowania
EP1889304A4 (en) COMPOSITIONS AND THERMOELECTRIC PROCESS
IL190885A0 (en) Immunogenic compositions and methods of use
HK1128487A1 (en) Compositions comprising fluoroolefins and uses thereof
HK1113689A1 (en) Novel cellular compositions and methods for their preparation
IL184834A0 (en) Compositions and methods for the manufacture thereof
EP1954685A4 (en) FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
EP1848438A4 (en) DIAMINOPHENOTHIAZINE COMPOSITIONS AND THEIR USE
EP2034973A4 (en) CAPSUED LABEL COMPOSITIONS AND METHOD OF MANUFACTURING THEREOF
ZA200710206B (en) Compositions and methods for inhibition of the JAK path-way
ZA200802239B (en) Methods and compositions for the expression of a polynucleotide of interest
ZA200805711B (en) Solid biocidal compositions and methods of using the same
EP1928252A4 (en) PIGGY COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
ZA200805079B (en) Immunostimulatory compositions and methods